Among these compounds, three compounds, NSC342715, NSC622394, and NSC609077, inhibited the phosphorylation of EGFR by 50% in the gefitinib-resistant H1975 lung cancer cell line (Table 4). The gene discussed is EGFR; the disease is lung cancer.